Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2134 (LINC02134)

Target
LINC02134
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-protein coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2134 (LINC02134) is a human gene that encodes a long intergenic non-coding RNA (lincRNA), a subclass of long non-coding RNAs that are autonomously transcribed sequences longer than 200 nucleotides and are located in regions of the genome not overlapping known protein-coding genes[1][3][5]. LincRNAs, including LINC02134, serve diverse regulatory roles such as fine-tuning expression of nearby genes, chromatin remodeling, RNA stabilization, and transcription regulation, often with tissue-specific expression[3][5]. While thousands of lincRNAs have been annotated in the human genome and some have been functionally investigated (notably in gene regulation and disease), LINC02134 does not, as of current knowledge, have a well-characterized biological function, explicit disease association, or therapeutic targeting reported in the literature. Thus, LINC02134 is not considered a therapeutic target like receptors, enzymes, or channels, but represents a regulatory non-coding RNA with potentially context-dependent cellular functions that remain to be fully elucidated[1][3][5].

Other names
LINC02134long intergenic non-coding RNA 2134
02

Biological functions

Regulation of gene expressionChromatin remodelingGenome architecture maintenancePossible enhancer-associated activity
03

Disease associations

Other (implicated roles for lincRNAs in various diseases, but no specific disease association described for LINC02134 as of current knowledge)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2134 (LINC02134).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2134 (LINC02134).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call